Powered 500 · 2026POWEREDS. 070 of 500
McClure co-founded Maxwell Biosciences to develop broad-spectrum compounds that hit viruses, bacteria, fungi, and biofilms — including currently untreatable infections — and has grown the Austin startup to Series A readiness ahead of FDA trials.
Scotch McClure is CEO, Chairman, and Co-Founder of Maxwell Biosciences, an Austin-based preclinical biotechnology company developing broad-spectrum anti-infective therapeutics targeting viruses, bacteria, fungi, and biofilms.
The company is raising a Series A ahead of FDA clinical trials and expanding government and corporate partnerships. McClure is an engineer with over 20 years as a CEO and 10 years as a corporate board director.
Interview · In Pipeline
Sponsored placement
An invitation, extended to Powered readers.
Drive the Continental GT S.
Request a test driveBentley T&Cs apply
